ABT-450/r/ABT-267

Phase 1Completed

0 views this week 0 watching💤 Quiet

Interest: 29/100

Hype Score

Development Stage

✓

Pre-clinical

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Absolute Bioavailability

Conditions

Absolute Bioavailability

Trial Timeline

Jan 1, 2014 → Feb 1, 2014

NCT ID

NCT02052362

About ABT-450/r/ABT-267

ABT-450/r/ABT-267 is a phase 1 stage product being developed by AbbVie for Absolute Bioavailability. The current trial status is completed. This product is registered under clinical trial identifier NCT02052362. Target conditions include Absolute Bioavailability.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT02052362	Phase 1	Completed	Jan 1, 2014	Feb 1, 2014	Absolute Bioavailability